IOF believes that innovation is the cornerstone of the future of orthodontics. Its mission is to foster the emergence and ...

L’avis préalable de réunion – comportant l’ordre du jour, les projets de résolutions proposés par le conseil d’administration, ainsi que les modalités de participation à l’Assemblée – a été publié au ...

The Preliminary Notice of Meeting – including the agenda, the draft resolutions proposed by the Board of Directors, and instructions for participation and voting to the Meeting – was published in the ...

As global demand for proton therapy grows, so does the need for multifaceted training. With many new centers emerging worldwide, The Proton Therapy Academy addresses a critical need for education and ...

Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA ; Evrysdi offers the same efficacy and safety demo ...

In addition to this recognition, Dr. Katie Bush, Senior Vice President of Scientific & Medical Affairs of AVITA Medical, was awarded the 2025 Emerald Pinnacle Healthcare Award in the Medical Device ...

Macias Gini & O’Connell LLP was appointed as auditors for the Corporation, to hold office until the next annual meeting of Shareholders of the Corporation, and the directors of the Corporation are ...

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner. Contacts: For ...

Based on market research, inguinal hernia repair is the most common type of hernia repair. MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commerc ...

The live webcast will be available to investors and other interested parties by accessing the Fortrea Investor Relations website. A webcast replay will be available after the event. Fortrea (Nasdaq: ...

The stock options are subject to the terms and conditions of Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan, as well as the terms and conditions of the stock option agreement covering the ...

MacroGenics (the Company) is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of ...